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INTRODUCTION
Infertility is defined as inability to have or to achieve
pregnancy and/or to maintain a pregnancy to reach
sufficient month after 12 months or after regular coi-
tus without any contraception.1,2
In United States, the infertility occurrence rates are
around 10 - 15% on reproduction age. In Indonesia,
it was estimated 12% couples were unable to have a
live child. Therefore, approximately 3 million indivi-
dual infertile couples are living across Indonesia.3,4
The real incidence of general factors are extremely
varied. In general, infertility could be caused by ano-
vulatory cycle (10 - 15%), pelvic factor (30 - 40%),
abnormalities of male reproduction tract (10 - 15%),
cervical factor (10 - 15%), and unknown factors.1,5,6
Cervical factors can be caused by the obstruction
of the cervical canal tract, abnormality of the cervical
mucus, cervical malposition, or a combination of any
of those factors. The cervix actually has an important
role in the capacity and sperm transport after coitus.
Cervical mucus assessment can be used as a liable
checking procedure in order to detect ovulation. The
amount of production, and the characteristic of cervi-
cal mucus are always changed based on the estrogen
concentration during follicular phase.1,7
Cervical mucus has a physical and chemical altera-
tion based on the menstruation cycle phase. During
proliferation phase to ovulation, the estrogen concen-
trations will stimulate the mucous formation. More-
over, the cervical mucus will be diluted by the de-
creased level of albumin and increased level of water
and mucin. The decreased viscosity of cervical mucus
during ovulation increase the capacity of sperm to
penetrate the cervical mucus. After ovulation, there
will be high progesterone concentrations which will
block the secretion activity of epithelial cells, result-
ing on the increase of cervical mucus viscosity and
density.5,7,8
Cervical mucus assessment can be used as parame-
ter to identity ovulation. Maximum score for cervical
mucus is 15. Score higher than 10 indicates a good
cervical mucus, which is easier to penetrate by sperm,
less than 10 score indicating a poor cervical mucus
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Abstrak
Tujuan: Untuk mengetahui pengaruh pemberian klomifen sitrat
terhadap kualitas getah serviks perempuan infertil.
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condition. This scoring for cervical mucus condition
or quality is based on the system developed by Mo-
ghissi (1976), which is based on original proposal in-
itiated by Insler and colleague (1972) as shown on
Table 1.7
Ovulation induction is a medical procedure to help
infertile women who suffer from hypothalamus pitui-
tary-ovarian axis dysfunction (anovulatory cycle). The
most popular stimulation agent which has been used
until now is clomiphene citrate. Based on the real fact,
out of 80 - 85% of previously treated women will
have the ovulation, and 40% of these ovulated women
will have pregnancy.3,9
The definite mechanism of clomiphene citrate is
still unknown. It is predicted that the anti-estrogenic
nature of clomiphene citrate might occupy estrogen
receptors in the hypothalamus and pituitary, resulting
in excretion of FSH and LH from pituitary. The in-
crement of gonadothropin level will sufficiently in-
duce follicular maturation andovulation. The mecha-
nism of action of clomiphene could induce the pro-
duction of endogenous estrogen.9,10
Clomiphene citrate has a good tolerability. How-
ever, some mild adverse effects could be found even-
though these are rarely become so serious that the
patient should discontinue the administration. Hot
flushes and mood alteration are regularly found. Mo-
rover, tension sensation on pelvic pain, visual dis-
tubance vomiting, and nausea sensation are rarely
found. Clomiphene citrates also have several effect
on the breast (tension sensation of breast), endocervix
(poor cervical mucus quality), endometrium (blocking
the endometrium development), and ovaries (causing
a spontaneous abortion). However, there was no data
supports the statement that clomiphene citrate could
induce significant clinical consequences.9,11,12
The poor quality of cervical mucus is one of side-
effects of clomiphene citrate as a consequence of its
anti-estrogenic nature. The alteration of cervical mu-
cus can cause motility disruption of sperm. The ad-
verse effect of clomiphene citrate to particular repro-
ductive organ might cause poor pregnancy figures, de-
spite good ovulation rate. However, the effect of
clomiphene citrate has still been argued.11,13
The indistinct condition and the fact that there were
no sufficient data regarding the quality of cervical
mucus assessment before and after clomiphene citrate
administration in Indonesia, particularly in Makassar
lead us to conduct this study.
METHODS
This study is a Non-Randomized Clinical Trial to ob-
serve the effect of clomiphene citrate administration
on the cervical mucus quality of infertile woman. The
study was held at several educational hospitals in
Makassar.
The sample population of this study was calculated
using Isaac and Michael formula, and 36 cases were
found. Samples were collected from population using
non-random sampling method, which had fulfilled the
inclusion and exclusion criteria. The inclusion criteria
were age ranged 20 - 40 years old, normal sperm
analysis, regular and irregular menstrual cycle, no
anatomical abnormalities, no history of gynecological
operation, no history of tumor/cancer or similar con-
dition in family medical history, and agree to partici-
pate in this study.
Recruited patients underwent initial cervical as-
sessment during their fertile period (after being con-
firmed bt LH test) clomiphane citrate 1 x 50 mg was
started on the second day of menstruation for 5 days
and 5 days after finished the drug patients underwent
second LH monitoring. If LH test was positive, pa-
tients were asked to undergo the second cervical mu-
cus assessment.
Cervical mucus sample was taken while patients
was lying in lithotomy position. Tuberculin hypoder-
mic needle 1 cc was used to aspirate the servical mu-
cus. Assessment was done as soon as possible, pH
evaluation was done using pH dipstic. Moreover, cer-
vical mucus will be observed under the microscope
to asses turning formation and cell composition.
The cervical mucus quality were then assessed us-
ing moghissi scores. If the score is ≤ 10, it is regarded
that the cervical mucus have a poor quality, if the
score is > 10, the cervical mucus is regarded to have
a good quality. The result was recorded in study forms
and analyzed using Wilcoxon Signed Rank Test.
RESULT
Thirty six infertile women were recruited. Most of the
patients aged between 26 - 30 years old (38.80%).
Most of them are college graduated 50%, and 47.2%
works as civil employed. Most subject have good nu-
trition. Duration of infertility were mostly between 1
- 5 years (52.8%) and most of them have experienced
fertility treatment before (61.1%). (Tabel 2)
Initial cervical assessment showed 52.8% subject
have good cervical mucus quality. On the contrary,
Table 1. Scoring for cervical mucus quality.
score volume Consistency Ferning spinn-barkeit cell-composition
0  0 ml Thick, good viscosity No crystallization < 1 cm > 20 cells/LPK - or > 1000 cells/mm3
1  0.1 Average Thickness Atypical 1 - 4 cm 11 - 20 cells/LPK - or 501 - 1000 cells/mm3
2  0.2 Less Thickness Primary and secondary stem 5 - 8 cm 1 - 10 cells/LPK or 1 - 500 cells/mm3
3 ≥ 0.3 Fluid Tertiary and quarter stem ≥ 9 cm 0 cell/LPK
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after cervical treatment, 77.8% of all subject showed
poor quality cervical mucus. There was a significant
alteron between cervical mucus quality.
Table 2. General Characteristic Distribution of Study Sample.
Characteristic Total
N %
Age (years)
< 25  2  5.6
26 - 30 14 38.9
31 - 35  8 22.2
36 - 40 11 30.6
> 40  1  2.8
Education
< 6  1  2.8
 6 -  9  1  2.8
10 - 12 16 44.4
> 12 18 50.0
Occupation
Housewives 15 41.7
Civil employee 17 47.2
Private employee  4 11.1
Nutritional status
Poor (underweight) - 0
Good (normal) 20 55.5
Excessive (overweight) 12 33.3
Obesity  4 11.1
Menstruation cycle
Regular 34 94.4
Irregular  2  5.6
Years of marriage/infertile
1 - 5 years 18 52.8
> 5 years 17 47.2
Previously treatment history
Treatment 22 61.1
No treatment 14 38.9
Source: primary data
Sample distribution according to pH rate of cervi-
cal mucus before and after clomiphene citrate admini-
stration treatment, showed no significant differences.
Highest pH rate of cervical mucus ranged from 6.1 -
8.0, either before clomiphene citrate administration
(74.9%) or after the administration of clomiphene cit-
rate (88.8%).
Between cervical mucus quality before and after
clomiphene citrate administration there was a signifi-
cant alteration (p < 0.05). It also show that most of
cervical mucus qualities were declining after the ad-
ministration of clomiphene citrate, as shown in 28
samples (77.8%). (Table 3)
Table 3. The comparative result of cervical mucus quality
before and after clomiphene citrate administration
treatment.
Final cervical
mucus quality
Initial cervical
mucus quality total
Poor Good
Poor N (%) 1336.1 1541.7  2877.8
Good N (%)  411.1  411.1   822.2
total N (%) 1747.2 1952.8 36100  
Wilcoxon Signed Rank Test with p < 0.05 (p = 0.012)
DISCUSSION
This study shows that most infertile woman were at
the age of 26 - 30 years old. With Hutterites and other
studies that stated this range of age (26 - 30 years
old) is marked as the highest fertility age of women
to have pregnancy. Older age will result in poorer
fertility.
Cervical mucus pH rate before and after clomi-
phene citrate administration showed no significant
differences. Highest pH rate was ranged from 6.1 -
8.0 for both conditions. This result was as expected
due to the fact that cervical mucus pH rate was not
affected by ovulated or non-ovulated cycle. Therefore,
the result was not caused by the effect of clomiphene
citrate administration.1,7
The quality alteration of the cervical mucus before
and after clomiphene citrate administration tends to
be worsen (p < 0.05). Table 3 shows that cervical
mucus score which was initially poor remain to be
poor after the treatment (36.1%), while the cervical
mucus which has good score initially after cervical
treatment showed declining of the mucus quality in
41.8% samples. In average, it shows that most of cer-
vical mucus quality after clomiphene citrate tends to
degrade, as happened in 77.8% samples.
Van Campenhout and colleague (1995) reported
that the administration of clomiphene citrate for 25 -
50 mg/day dosage would partially block the enhance-
ment of Spinnbarkeit of cervical mucus. Gysler and
colleague (1995) found only 15% of their sample had
poor cervical mucus quality. However, this study
showed that there were 22.2% subject that which had
good cervical mucus quality after clomiphene citrate
administration in other hand, 11.1% samples showed
poor cervical mucus quality before the treatment but
have increased quality after the treatment. Due to
these facts, it is assumed that this condition may be
affected by various factors, including age, previously
treatment history and sample collecting timing of
sample collection.1,13-15
CONCLUSION
The administration of clomiphene citrate may cause
worsening of cervical mucus quality. The administra-
tion of estrogen preparation along with clomiphene
citrate might be considered, in repeated clomiphene
citrate therapy.
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